DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,844,000 | -19.7% | 63,423 | +2.2% | 0.41% | -28.3% |
| Q4 2020 | $3,542,000 | +11.3% | 62,065 | +0.1% | 0.57% | -14.0% |
| Q3 2020 | $3,181,000 | -12.9% | 62,009 | +1.4% | 0.66% | -14.4% |
| Q2 2020 | $3,653,000 | +68.8% | 61,168 | +16.4% | 0.78% | +19.0% |
| Q1 2020 | $2,164,000 | -33.8% | 52,569 | +0.1% | 0.65% | -2.8% |
| Q4 2019 | $3,269,000 | +87.2% | 52,517 | +2.1% | 0.67% | +44.8% |
| Q3 2019 | $1,746,000 | – | 51,451 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |